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〈〉原著論文
1) Hamazaki K., Itomura M., Huan M., Nishizawa H., Sawazaki S., Tanouchi M., Watanabe S., 
Hamazaki T., Terasawa K., and Yazawa K.: Effect of ro・3 fatty acid-containing 
phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, 
placebo-controlled, double-blind trial. Nutrition, 21: 705・710,2005. 
Abstract: Objectives: We previously reported that administration of fish oil rich in docosahexaenoic 
acid (DHA) increased the plasma ratio of epinephrine to norepinephrine (NE) at rest in young adults who 
were under chronic stress and that this effect was achieved mainly through depression of NE. However, 
not many reports have documented the effects of eicosapentaenoic acid (EPA) and DHA on blood 
catecholamine levels in healthy humans. Therefore, we performed another intervention study to test their 
effect on catecholamines with healthy subjects under no chronic stres. 
Methods: Twenty-one healthy young adults (15 men and 6 women) were randomly assigned to an 
omega-3 group (n = 9) or a control group (n = 12) in a double-blind manner. Twenty capsules of 
shellfish-derived lipids containing 762 mg of EPA plus DHA per day were administered to the omega-3 
group for 2 mo. The controls took the same amount of placebo capsules. Fasting blood samples after a 
30-min rest with a catheter in a forearm vein were obtained at the start and the end of the study for 
catecholamine measurements. 
Results: EPA but not DHA concentrations in red blood cells significantly increased in the omega-3 group 
compared with the control group (P < 0.001). Plasma NE concentrations were significantly decreased in 
the omega-3 group （企om1.49 ＋／ー 0.39nmol/L to 1.05 ＋／ー 0.14nmol/L) compared with the control group 
（企om1.12十／ー 0.24nmol/L to 1.39 ＋／ー 0.32nmol/L) with analysis of covariance (P < 0.001). The 
differences remained significant (P = 0.01) even after deletion of three subjects in the omega-3 group who 
had the highest baseline NE values and one in the control group who had the lowest baseline NE value to 
nullify a significant baseline differences in NE between groups. Conclusion: This study demonstrated 
that EPA plus DHA supplementation lowered plasma NE concentrations in normal volunteers even at the 
small dose of 762 mg of EPA plus DHA per day. This effect of EPA plus DHA to lower plasma NE 
concentrations may be important to understand some of the effects of fish oils on diseases. 
2) Itomura M., Hamazaki K., Sawazaki S., Kobayashi M., Terasawa K., Watanabe S., and 
Hamazaki T.: The effect of fis oil on physical aggression in schoolchildren -a randomized, 
double-blind, placebo-controlled trial. J. Nutr. Biochem., 16: 163・171,2005. 
Abstract: Objectives: The aim of the study was to investigate whether fish oil supplementation affected 
Japanese schoolchildren’s behavior, with changes in aggression over time as the primary endpoint. 
Design and subjects: A placebo-controlled double-blind study with 166 schoolchildren 9-12 years of age 
was performed. The subjects of the fish oil group (nニ83)took fish oil-fortified foods (bread, sausage and 
spaghetti). These foods were provided in amounts such that each subject in the fish oil group had an intake 
of3600 mg of docosahexaenoic acid+840 mg of eicosapentaenoic acid (EPA)/week for 3 months. The rest 
(the controls, n=83) took control supplements. At the start and end of the s旬dy,psychological tests were 
performed to assess their aggression. 
Results: Physical aggression assessed by Hostility-Aggression Questionnaire for Children in girls 
77 
increased significantly (median: 13 to 15, n=42) in the control group and did not change (13 to 13, n=43) 
in the fish oil group with a significant intergroup difference (P=.008) with baseline as covariate. The 
changes in physical aggression scores over time and those of the ratio of EPA/arachidonic acid in RBC 
(DeltaEPA/AA) were significantly correlated in girls who agreed to blood collection (r=-.53, P=.01, 
n=23). On the contrary, there were no significant changes in physical aggression in boys. Aggression 
against others (extraggression) assessed by Picture Frustration Study did not change in the control group 
(median: 5 to 5) but increased significantly in the fish oil group ( 4 to5) with a significant intergroup 
difference (Pニ.02)with baseline as covariate. These changes in extraggression might be explained partly 
by significantly lower baseline values of extraggression in the fish oil group (P=.02) than in the control 
group. There were no significant correlations between Deltaextraggression and DeltaEPA/ AA in 
blood-sampled children (n=49). Impulsivity of girls assessed by parents/guardians using the diagnostic 
criteria for attention deficit/hyperactivity disorder of DSM-IV was reduced in the fish oil group (1 to 0) 
with a significant (P=.008) intergroup difference from the control group (1 to 1 ). There were no 
significant correlations between Deltaimpulsivity and DeltaEPA/ AA in blood-sampled girls. In males, 
impulsivity reduced in both groups without any intergroup differences. 
Conclusion: There is a possibility that changes in fatty acid nutrition might affect physical aggression 
especially in girls. 
3) Takenaka M., Kanada S., Hamazaki T., and Watanabe S. : Dietary supplementation with n-3 
polyunsaturated fatty acids attenuates the depression of food-motivated behavior during 
zymosan-induced peritonitis. Biol. Pharm. Bull., 28: 1291・1293,2005
Abstract: Peripheral inflammation is accompanied by neurobehavioral alterations such as depression of 
feeding, explorato巧fand sexual behavior. Our previous investigation reported that dietary enrichment 
with n-J polyunsaturated fatty acids (PUFA) attenuated the depression of food-motivated behavior and 
social exploration, but not endocrinological and metabolic disturbances in the mice wuith systemic 
inflammation induced by lipopolysaccharide (LPS). We here demonstrate that dietary n-3 PUFA also 
attenuate the reduction of food-motivated behavior during zymosan-induced peritonitis in mice without 
influencing plasma leakage into peritoneum and writhing response. Our results suggest that the common 
mechanism is involved in the attenuation of depression during systemic and local inflammation by 
dietary n-3 PUFA. 
4) Saito M., Hamazaki T., Tani T., and Watanabe S.: Bofutsushosan, a traditional Chinese 
formulation, inhibits pancreatic lipase activity in vitro and suppression the elevation of 
plasma triacylglycerols after oral administration of lipid emulsion. J. Trad. Med., 22: 
308・313,2005
Abstract: Pancreatic lipase activity measured as fatty acid liberation from lipid emulsion was shown to be 
inhibited by the addition of Bofutsushosan (BOF) or Daijokito (DJT) extracts at > 30mg/ml. The extracts 
of Orengedokuto (OGT), Chotosan (CTS), Boiogito (BOT) or Shibuto (SBT) were ineffective in 
inhibiting pancreatic lipase activity upto 60 mg/ml. Mice were orally administered with a lipid emulation 
in the presence of BOF extracts at 750 and 2250 mg/kg and subsequent elevation・ of plasma 
triacylglycerols (TAG) was significantly suppressed as compared with that in the mice which received 
lipid emulasion alone. However, the addition of DJT extracts did not suppress the elevation of plasma 
TAG after oral administration of lipid emulsion. Our results suggest that BOF suppress the absorption of 
ingested fats and this effect could account for the anti-obese effects of BOF. 
5) Morita M., Takahashi I., Kanai M., Okafuji F叫 IwashimaM., Hayashi T., Watanabe S叫
Hamazaki T叫 ShimokawaN., Suzuki Y., Furuya H., Yamada T., and Imanaka T.: Baicalein 
5ム7-trimethylether, a flavonoid derivative, stimulates fatty acid f3-oxidation in skin 
fibroblasts of X岨linkedadrenoleukodystrophy. FEBS Letι，579: 409-414, 2005 
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Abstract: The pu中oseof the present study is to identify compounds with potential for X-linked 
adrenoleukodystrohpy (X-ALD) pharmacological therapy. Various plant natural products including 
flavonoids were tested for their ability to ameliorate the abnormality of veηr long chain fatty acid 
(VLCFA) metabolism in cultured skin-fibroblasts 企omX-ALD patients. Of the compounds tested, 
baicalein 5ム7-trimethylether (baicalein-tri-Me) was found to be significantly stimulate the VLCFA 
~－oxidation activity. Furthermore, the inco中orationof [ 1-14C]lignoceric acid into cholesteryl esters was 
markedly redcued towards the decreased. These results make baicalein-tri-Me a candidate for the 
therapeutic compounds for X-ALD. 
6) Nakamura N .,Kumasaka R., Osawa H., Yamabe H., Shirato K., Fujita T., Murakami R叫
Shimada M, Nakamura M., Okumura K., Hamazaki K, and Hamazaki T.: Effects of 
Eicosapentaenoic Acids on Oxidaitive Stress and Plasma fatty Acid Composition in Patients 
with Lupus Nephritis. in vivo, 19: 879-882, 2005. 
Abstract: Eicosapentaenoic acid (EPA) is one of the major components offish oilラwhichwas reported to 
have antiatherogenic, anti-inflammatory and immune suppressive effects. In the present study, highly 
purified EPA was administered to patients with lupus nephritis and the effects of EPA on urinary 
8・isoprostane,a reliable marker of oxidative stres, were investigated in these patients. Six outpatients ( 1 
man and 5 women), with lupus nephritis diagnosed by renal biopsy, were entered in the study. We 
administered 1800 mg EPA ethyl-ester (purity> 95%) daily and examined the urinary 8-isoprostane levels 
and plasma fatty acid composition before and 3 months after EPA treatment. The urinary 8-isoprostane 
levels were significantly decreased after the treatment compared with those before the treatment （企om
530 ＋／ー 113pg/mg x Cr to 235 ＋／ー 49pg/mg x Cr, p = 0.02). The EPA levels in the plasma phospholipid 
(PL) fraction were significantly increased after the treatment (from 3.30 ＋／ー 0.64mol% to 8.01 ＋／ー 0.47
mol%, p < 0.001). Arachidonic acid (AA) levels in the plasma PL fraction were significantly decreased 
after the treatment (from 9.47 ＋／・0.28mol% to 7.33 ＋／ー 0.43mol%, p < 0.001). The ratios of EPA to AA 
were significantly increased after the treatment (from 0.35 ＋／ー 0.07to 1.14 +/-0.16, p < 0.001). Thus, this 
preliminary study indicated that EPA might exert beneficial effects on lupus nephritis by decreasing the 
oxidative stres. 
7) Kobayakawa M., Yamawaki S., Hamazaki K., Akechi T., Inagaki M., and Uchitomi Y.: 
Levels of omega-3 fatty acid in serum phosph91ipids and depression in patients with lung 
cancer. Bκi Cancer, 93: 1329・1333,2005. 
Abstract: Previous studies suggested that omega-3 fatty acids (FAs) have therapeutic effects against 
depression, but there is no evidence in the oncological setting. Our preliminary study reported the 
association between lower omega-3 FA intake and occu汀enceof depression in lung cancer patients. To 
explore the association further, the present study examined whether depression was associated with lower 
levels of omega-3 FAs in serum phospholipids. A total of 717 subjects in the Lung Cancer Database 
Project were divided into three groups by two cutoff points of the Hospital Anxiety and Depression Scale 
depression subscale (HADS-D). In al, 81 subjects of the nondepression and minor depression groups 
(HADS-D<5 and 5<or=HADS-D<or=l0, respectively) were selected to match with 81 subjects of the 
major depression group (HADS-D> 10) for age, gender, clinical stage, and performance status. Fatty acids 
were assayed by gas chromatography and compared among the three matched groups. There were no 
differences between the major depression group and nondepression group in any FAs. The minor 
depression group had higher mean levels of docosahexaenoic acid (mean＋／”s.d. (% ),nondepression: 
7.40＋／ー 1.54;minor depression: 7 .90＋／ー 1.40;major depression: 7 .25＋／噂1.52,P=0.017). These results 
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8) Hamazaki T.: The japanese atherosclerosis society recently published ‘Desirable cholesterol 
levels'. But is it necessary to lower them below 240? 4th International Congress on the Colunbus 
Concept. 2005, 10, Beijing. 
9) Hanawa N., Deguchi M., Hamazaki K., Hamazaki T., Saiki Y. and Yamaguchi M.: Evaluation of 
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